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public health and social sciences. This article discusses the implications of the recent advances of neuro-
biology for policies especially as they pertain to adolescents in low- and middle-income countries. It
includes an overview of adolescent use of illicit drugs in low- and middle-income countries and calls for
a move toward a transdisciplinary approach. It presents some of the challenges for research aimed at
increasing our understanding of the issue and for policy.
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Open access under CC BY-NC-ND license.Addiction to illicit drugs is a substance use disorder that often
takes root during the adolescent years and affects individuals in
high-income countries as well as those in low- and middle-
income countries (LMICs). A consistent pattern in the age of
onset of substance use disorders has been documented, with
a rapid increase in onset during late adolescence and early
adulthood [9]. The developmental processes as well as the events
and environments of adolescence likely shape later risk of
developing such problems. There is evidence that early initiation
increases the risk of dependence [4].
Recent advances in the neurobiology of addiction have
expanded our understanding of the effects of illicit drugs on the
human brain and in particular on the adolescent brain. Further-
more, research on the interplay betweenmental health disorders
and substance use disorders has indicated opportunities for
intervention. Although this new knowledge has the potential to
improve prevention and treatment, translating these scientiﬁc
advances into better policies requires collaboration and dialogue
between the social sciences and the biological sciences.
This article discusses the implications of the recent advances
in the neurobiology of addiction for policies relating toadolescent addiction especially as they pertain to LMICs. It is
introduced by a brief overview of the adolescent use of illicit
drugs in LMICs followed by a discussion of how advances in both
neurobiology and mental health research pertain to adolescents
in low-resource settings.Illicit Drugs and Adolescents in Low- and Middle-Income
Countries
Despite global variations in rates of illicit substance use, the
World Mental Health Survey Initiative indicates that substance
dependence and abuse are problems in both high- and low-
income countries. Although the highest rates are found in
high-income countries such as the United States and New Zea-
land [11,16], relatively high rates are also found in selected
middle-income countries in various geographic regions. In South
Africa, the rate of substance abuse is 3.9% and the rate of
substance dependence is 0.6% [8]. Substance abuse is less prev-
alent in Mexico at 2.7%, but the rate of dependence is 0.8% [13].
Although LMICs have lower rates of illicit drug use, individ-
uals with substance abuse problems experience higher mortality
and are less likely to receive treatment than their counterparts in
high-income countries. A review of mortality rates of opioid
users found that individuals in lower income countries had
higher crude mortality rates than those in higher income
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According to the World Mental Health Survey in the United
States, more than half of individuals with substance dependence
received treatment [11], whereas in Mexico only 17% received
treatment [15]. Furthermore, during the ﬁrst year of onset of
substance abuse disorders, only 2.8% received treatment in
Nigeria and China and only 0.9% in Mexico [22].
High rates of illicit drug use among adolescents in LMICs have
been documented, with estimates ranging from 5.2% of 12 to 17
year olds in Mexico City [3] to 10.5% of 13- to 15-year-old
students in sub-Saharan Africa [18]. Although the methods and
deﬁnitions used in deriving such estimates vary, the magnitude
of such ﬁgures is cause for concern. Illicit drug use among
adolescents contributes to serious health consequences. Among
individuals ages 15 to 24, 2% of the global disability-adjusted life-
years (DALYs) are attributable to illicit drug use. The only risk
factors that are responsible for a greater share of DALYs are
alcohol use, which accounts for 8% of DALYs, and unsafe sex,
which accounts for 5% of DALYs [7].
Among adolescents in developing countries illicit drug use is
associated with numerous other risk behaviors and risk factors,
which may either contribute to or be the result of the drug use. A
study of adolescents in three Central American countries found
that problems with drugs were associated with risk factors
including family drug use, school disengagement, peer deviance,
and exposure to violence [12]. Adolescents who use illicit drugs
have been shown in a variety of LMICs to be at increased risk of
tobacco and alcohol use [6,18]. Understanding the association
between these risk factors and illicit drug use can be challenging
because many data sets are cross-sectional and cannot establish
temporality between risk factors and the onset of substance use.
In Mexico, the median age of onset for drug use disorders is 17
years, whereas the age of onset for alcohol and nicotine depen-
dence is 25 years [14], suggesting in conjunction with studies
that show clustering of illicit drug use with alcohol and tobacco
use that early initiation of illicit drug use may lead to subsequent
alcohol and tobacco problems. An increased understanding of
the neurobiology of addiction in adolescents may contribute to
further untangling the mechanisms of risk and protective factors
and identifying effective points of intervention.
Neurobiology of Addiction and Mental Health in
Adolescents
Understanding the neurobiological mechanisms of addiction
in adolescents can strengthen our understanding of why they are
particularly susceptible to addiction and indicate how to inter-
vene. Early initiation of use of substances, such as tobacco, has
been shown to increase the probability of reinitiating use later on
in adulthood in both animal models [1] and in studies with
humans [14]. The same pattern is likely applicable to use of illicit
substances, indicating the importance of addressing substance
use during the adolescent years to reduce the risk of later
addictions.
Potenza [19] gives an overview of the current research on the
neurobiological mechanisms of addiction, which are important
in explaining adolescent vulnerability to addiction. One mecha-
nism of addiction that Potenza describes is the process of
deciding between immediate rewards and long-term goals, such
as the completion of education, which occurs in the prefrontal
cortical brain regions. This is particularly relevant for adolescents
as development of this region of the brain continues into the teenyears and explains in part why they may be more likely than
older adults to choose the short-term rewards, such as a drug-
induced high, over long-term goals. Furthermore, the cycle of
increased impulsivity following initial exposure to substances
can lead to increased chances of developing an addiction, further
emphasizing the importance of delaying initial exposure to
addictive substances.
Comorbidity between substance abuse disorders and other
mental health disorders further complicates prevention and
treatment approaches [17]. The increased risk of developing drug
dependence when mental health disorders pre-exist suggests
that treating mental disorders at an early age may be an
important prevention strategy. Kessler et al. [10] estimated the
effects of mental disorders in predicting the subsequent ﬁrst
onset of drug use problems and dependence and found that the
odds ratios for effects on dependence ranged from 3.3 and 14 for
anxiety disorders and between 4.4 and 18.6 for mood disorders.
The ages of onset for primary mental disorder and subsequent
drug dependence show a window of opportunity for preventive
interventions. A period of between 5 and 8 years after the onset
of the primary mental disorder and the onset of the secondary
drug use disorder was observed for most mental disorders.
Mental disorders were associated with half of all drug depen-
dence (54% among men and 48% among women).
Improvements in our understanding of the neurobiology of
addiction as well as an increased awareness of the connections
betweenmental health disorders and substance use problems are
highly relevant for adolescents. The window of opportunity
between the onset of mental health disorders and substance use
problems will occur during adolescents for many individuals. To
effectively reach all adolescents including high-risk individuals
withmental healthdisorders, interventions that take intoaccount
what is known about the neurobiology of addiction are needed.
Recommendations for Policies and Programs
An increased understanding of how illicit substance use
affects the adolescent brain should inform policies in LMICs.
Addressing addiction in the adolescent years involves not only
treatment, but also a large focus on prevention, both of which can
be informed by advances in research. Neglecting to acknowledge
the neurobiological realities may result in scarce resources
wasted on failed treatment and prevention programs.
Patterns of illicit druguse varywidelyamongcountries andare
important indetermininghowtodesigneffective responses to the
problem. Forexample, inAfrica themajority of treatment demand
is accounted for by cannabis, whereas in Asia opioids dominate
treatment demand and in South America cocaine is most prom-
inent [21]. Despite variation in speciﬁc responses, correlates of
illicit substance use in LMICs indicate that effective programs
should focus on multiple contexts, including individual, family,
school, and community [3,12,18]. Although studies from the social
sciences have indicated where to intervene, research in the
biomedical sciences can help identify how to intervene.
Although a review conducted by Barbor et al. [2] suggests that
some drug prevention programs work, there is strong evidence
that many programs have not been effective, and in particular
many nonescience-based programs have failed to achieve their
desired results. The improved understanding of the underlying
mechanisms in the brain that explain the development of
dependence brings the possibility of developing efﬁcient drug
therapies that could prevent addictive substances from reaching
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have been more successful than clinical studies with humans,
this is an important area for future research. While the neuro-
biology of addiction is directly applicable to the development of
effective pharmacotherapeutic treatments, this approach to
treating addiction is not always easily implemented in low-
resource settings. However, the neurobiological mechanisms
can also inform behavioral interventions. Romer and Hennessy
[20] recommend physical exercise interventions as a way to
delay or prevent initiation of substance use. Physical exercise
may provide an outlet for the sensation seeking impulses that are
not yet fully tempered by the less developed prefrontal cortex of
adolescents.
Beyond the design of effective interventions, having a strong
understanding of the neurobiological mechanisms can help
justify the importance of targeting prevention efforts in adoles-
cent years. Showing that interventions are well-informed and
based on knowledge of these neurobiological pathways may
further encourage policy makers that the proposed solutions will
reduce the burden of adolescent use of illicit substances.
The reviewof neurobiologicalmechanisms of addiction [19] as
well as the article on the comorbidities ofmental health disorders
and drug use [17] in this volume highlight the recent scientiﬁc
advances in the ﬁeld of addiction. Although the manifestation of
problems associated with illicit drug use varies across countries
and within different subpopulations, certain lessons can be
learned from these advances and applied to the prevention and
treatment of addiction for adolescents in LMICs. Major factors
relating to the risk of developing substance use disorders are
sociocultural and include exposure to violence, social tolerance of
drugs, and drug availability. These advances in neurobiology and
mental health point to the importance of integrating social
sciences and biological sciences while moving from a multidisci-
plinary approach to a transdisciplinary approach in order to
most effectively improve health outcomes for adolescents.
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